Advertisement

Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

Novo Seeds

Novo A/S is the holding company of the Novo Group, and is wholly owned by the Novo Nordisk Foundation. Novo A/S was established in 1999 to manage the assets of the Foundation and actively make investments on behalf of the Foundation. Novo A/S is not a corporate strategic fund; Novo A/S invests for financial rather than strategic returns. Novo A/S is active in both Europe and North America. The Novo A/S venture investments are managed by a team of four Partners in Copenhagen, one in London and three in San Francisco. With an evergreen structure, Novo A/S annually invests approximately EUR 200 million through Novo Ventures, Novo Seeds, and Novo Growth Equity. In total Novo A/S has more than EUR 15 billion under management, which includes significant shareholdings in the independently operating and publicly listed companies Novo Nordisk A/S and Novozymes A/S. *

 

Period Start 2011-05-03 existent
  Group Novo Group (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Christgau, Stephan (Eir Ventures 202007– before Novo Seeds + Osteologix)
  Person 2 Grotkjær, Thomas (Novo Group 201809 Principal at Novo Seeds)
     
Region Region Hellerup
  Country Denmark
  Street 19 Tuborg Havnevej
c/o Novo A/S
  City 2900 Hellerup
  Tel +45-3527-6500
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: 
     
   
Record changed: 2021-05-01

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Novo Group (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px




» top